Your browser doesn't support javascript.
loading
A pilot study of the effect of rivaroxaban in sickle cell anemia.
Ataga, Kenneth I; Elsherif, Laila; Wichlan, David; Wogu, Adane F; Matsui, Neil; Pawlinski, Rafal; Cai, Jianwen; Key, Nigel S.
Afiliação
  • Ataga KI; Center for Sickle Cell Disease, University of Tennessee Health Scienter Center, Memphis, Tennessee, USA.
  • Elsherif L; Center for Sickle Cell Disease, University of Tennessee Health Scienter Center, Memphis, Tennessee, USA.
  • Wichlan D; Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Wogu AF; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Matsui N; Vanguard Therapeutics, Inc., Half Moon Bay, California, USA.
  • Pawlinski R; Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Cai J; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Key NS; Division of Hematology and Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA.
Transfusion ; 61(6): 1694-1698, 2021 06.
Article em En | MEDLINE | ID: mdl-33660875

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Inibidores do Fator Xa / Rivaroxabana / Anemia Falciforme Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transfusion Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Coagulação Sanguínea / Inibidores do Fator Xa / Rivaroxabana / Anemia Falciforme Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transfusion Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos